Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Craig

Showing results (281-290 of 302) with videos related to

Pageof 31
Sort By:
Hematological Oncology|March 2, 2011
Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan-based reduced toxicity conditioningMehdi Hamadani, Michael Craig, Gary S Phillips, et al.
Brain : a Journal of Neurology|July 30, 2014
Response inhibition and serotonin in autism: a functional MRI study using acute tryptophan depletionEileen Daly, Christine Ecker, Brian Hallahan, et al.
Blood|March 5, 2014
Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT studyIan W Flinn, Richard van der Jagt, Brad S Kahl, et al.
Biological Psychiatry|September 6, 2005
Influence of X chromosome and hormones on human brain development: a magnetic resonance imaging and proton magnetic resonance spectroscopy study of Turner syndromeWilliam J Cutter, Eileen M Daly, Dene M W Robertson, et al.
BMJ Neurology Open|February 5, 2025
Spinal cord demyelination predicts neurological deterioration in patients with mild degenerative cervical myelopathyAbdul Al-Shawwa, Michael Craig, Kalum Ost, et al.
Spine|November 30, 2021
Cervical Sagittal Alignment in Patients with Cervical Spondylotic Myelopathy: An Observational Study From the Canadian Spine Outcomes and Research NetworkNathan Evaniew, Raphaële Charest-Morin, W Bradley Jacobs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2012
Clofarabine plus cytarabine compared with cytarabine alone in older patients with relapsed or refractory acute myelogenous leukemia: results from the CLASSIC I TrialStefan Faderl, Meir Wetzler, David Rizzieri, et al.
Blood|March 1, 2011
Phase 2 trial of romidepsin in patients with peripheral T-cell lymphomaRichard L Piekarz, Robin Frye, H Miles Prince, et al.
MMWR. Morbidity and Mortality Weekly Report|April 6, 2018
Vital Signs: Containment of Novel Multidrug-Resistant Organisms and Resistance Mechanisms - United States, 2006-2017Kate Russell Woodworth, Maroya Spalding Walters, Lindsey M Weiner, et al.
Transplantation and Cellular Therapy|April 7, 2022
Impact of Center Experience with Donor Type on Outcomes: A Secondary Analysis, Blood and Marrow Transplant Clinical Trials Network 1101Open for Accrual June 2012Open for Accrual June 2012Claudio G Brunstein, Paul V O'Donnell, Brent Logan, et al.
Pageof 31

Showing results (281-290 of 302) with videos related to

Sort By:
Pageof 31
Hematological Oncology|March 2, 2011
Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan-based reduced toxicity conditioningMehdi Hamadani, Michael Craig, Gary S Phillips, et al.
Brain : a Journal of Neurology|July 30, 2014
Response inhibition and serotonin in autism: a functional MRI study using acute tryptophan depletionEileen Daly, Christine Ecker, Brian Hallahan, et al.
Blood|March 5, 2014
Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT studyIan W Flinn, Richard van der Jagt, Brad S Kahl, et al.
Biological Psychiatry|September 6, 2005
Influence of X chromosome and hormones on human brain development: a magnetic resonance imaging and proton magnetic resonance spectroscopy study of Turner syndromeWilliam J Cutter, Eileen M Daly, Dene M W Robertson, et al.
BMJ Neurology Open|February 5, 2025
Spinal cord demyelination predicts neurological deterioration in patients with mild degenerative cervical myelopathyAbdul Al-Shawwa, Michael Craig, Kalum Ost, et al.
Spine|November 30, 2021
Cervical Sagittal Alignment in Patients with Cervical Spondylotic Myelopathy: An Observational Study From the Canadian Spine Outcomes and Research NetworkNathan Evaniew, Raphaële Charest-Morin, W Bradley Jacobs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2012
Clofarabine plus cytarabine compared with cytarabine alone in older patients with relapsed or refractory acute myelogenous leukemia: results from the CLASSIC I TrialStefan Faderl, Meir Wetzler, David Rizzieri, et al.
Blood|March 1, 2011
Phase 2 trial of romidepsin in patients with peripheral T-cell lymphomaRichard L Piekarz, Robin Frye, H Miles Prince, et al.
MMWR. Morbidity and Mortality Weekly Report|April 6, 2018
Vital Signs: Containment of Novel Multidrug-Resistant Organisms and Resistance Mechanisms - United States, 2006-2017Kate Russell Woodworth, Maroya Spalding Walters, Lindsey M Weiner, et al.
Transplantation and Cellular Therapy|April 7, 2022
Impact of Center Experience with Donor Type on Outcomes: A Secondary Analysis, Blood and Marrow Transplant Clinical Trials Network 1101Open for Accrual June 2012Open for Accrual June 2012Claudio G Brunstein, Paul V O'Donnell, Brent Logan, et al.
Pageof 31